Stribild is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Avera Mckennan Hospital. The primary component is Elvitegravir; Cobicistat; Emtricitabine; Tenofovir Disoproxil Fumarate.
Product ID | 69189-1201_ba8255c3-a4e3-4e8d-97bd-27c4b018c553 |
NDC | 69189-1201 |
Product Type | Human Prescription Drug |
Proprietary Name | Stribild |
Generic Name | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2015-10-28 |
Marketing Category | NDA / NDA |
Application Number | NDA203100 |
Labeler Name | Avera McKennan Hospital |
Substance Name | ELVITEGRAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
Active Ingredient Strength | 150 mg/1; mg/1; mg/1; mg/1 |
Pharm Classes | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2015-10-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA203100 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-10-28 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
ELVITEGRAVIR | 150 mg/1 |
SPL SET ID: | 8ac4d501-7f05-426e-93be-a42240087b0c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50090-1318 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
53808-0887 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
61958-1201 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
69189-1201 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
70518-0674 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
STRIBILD 85688699 4320307 Live/Registered |
GILEAD SCIENCES IRELAND UC 2012-07-27 |
STRIBILD 85555217 4263613 Live/Registered |
GILEAD SCIENCES IRELAND UC 2012-02-28 |